John Cuozzo
SVP, Head of Drug Discovery
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
John Cuozzo is the Senior Vice President and Head of Drug Discovery at VantAI in the United States. His research focuses on innovative approaches to drug discovery, including the development of novel inhibitors through DNA-encoded chemical libraries and machine learning techniques. Recent articles authored by him explore significant advancements in cancer immunotherapy, the identification of potent TAK1 inhibitors, and effective treatments for various diseases, highlighting his commitment to addressing critical issues in pharmaceutical science.
Articles (8)
Year:
2023
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (4)
Marina Fabbi
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro
Stefano Ugel
Associate Professor
University of Verona
Giulio Fracasso
University of Padua
MAURO GIACCA
Professor of Cardiovascular Sciences
King’s College London
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.